Factor XIII

Source: Wikipedia, the free encyclopedia.
Chr. 6 p24.2-p23
Search for
StructuresSwiss-model
DomainsInterPro
Chr. 1 q31-q32.1
Search for
StructuresSwiss-model
DomainsInterPro

Factor XIII or fibrin stabilizing factor is a

crosslinks fibrin. Deficiency of XIII worsens clot stability and increases bleeding tendency.[1]

Human XIII is a

B peptides. XIIIa is a dimer of activated A peptides.[1]

Function

Within blood,

Both of the non-

covalently bound B units are now able to dissociate from the tetramer with the help of calcium ions (Ca2+) in the blood; these ions also activate the remaining dimer of two A units via a conformational change.[1]

Factor XIIIa (dimer of two active A units) crosslinks fibrins within the clot by forming isopeptide bonds between various glutamines and lysines of the fibrins. These bonds make the clot physically more durable and protect it from premature enzymatic degradation (fibrinolysis).[1]

In humans,

α2-macroglobulin is a significant non-proteolytic inhibitor.[1]

  • Activation peptides (pink) of A units are removed by thrombin (IIa) in the presence of fibrin. B units (gray) are released with the help of calcium and A unit dimer is activated (XIIIa forms).
    Activation peptides (pink) of A units are removed by thrombin (IIa) in the presence of fibrin. B units (gray) are released with the help of calcium and A unit dimer is activated (XIIIa forms).
  • XIIIa crosslinks fibrin (simplified picture)
    XIIIa crosslinks fibrin (simplified picture)

Genetics

Human factor XIII consist of A and B subunits. A subunit

3' UTR of 1.6 kbp. F13A1 exon(s)[1]

  • 1 code 5' UTR
  • 2 code activation peptide
  • 2–4 code
    β-sandwich
  • 4–12 code
    catalytic domain
  • 12–13 code
    β-barrel
    1
  • 13–15 code β-barrel 2

B subunit gene is

F13B. It is on chromosome 1 at the position 1q31–32.1. It spans 28 kpb, has 11 introns and 12 exons. Its mRNA is 2.2 kbp. Exon 1 codes 5' UTR. Exons 2–12 code the 10 different sushi domains.[1]

Structure

Factor XIII of human blood is a

covalently bound B units form a ring-like structure around the center. B units are removed when XIII is activated to XIIIa. Dimers containing only A units also occur within cells such as platelets. Large quantities of singular B units (monomers) also occur within blood. These dimers and monomers are not known to participate in coagulation, whereas the tetramers do.[1]

A units have a mass of about 83

C-terminal, residue numbers are in brackets):[1]

B units are

Physiology

A subunits of human factor XIII are made primarily by platelets and other cells of bone marrow origin. B subunits are secreted into blood by hepatocytes. A and B units combine within blood to form heterotetramers of two A units and two B units. Blood plasma concentration of the heterotetramers is 14–48 mg/L and half-life is 9–14 days.[1]

A clot that has not been stabilized by FXIIIa is soluble in 5 mol/L urea, while a stabilized clot is resistant to this phenomenon.[2]

Factor XIII deficiency

consanguineous marriage.[3]

Diagnostic use

Factor XIII levels are not measured routinely, but may be considered in patients with an unexplained bleeding tendency. As the enzyme is quite specific for monocytes and macrophages, determination of the presence of factor XIII may be used to identify and classify malignant diseases involving these cells.[4]

Discovery

Factor XIII Deficiency is also known as Laki–Lorand factor, after Kalman Laki and Laszlo Lorand, the scientists who first proposed its existence in 1948.[2] A 2005 conference recommended standardization of nomenclature.[4]

See also

References

  1. ^
    S2CID 24703788
    .
  2. ^ .
  3. ^ Dorgalaleh A, Naderi M, Hosseini MS, Alizadeh S, Hosseini S, Tabibian S, et al. (2015). "Factor XIII Deficiency in Iran: A Comprehensive Review of the Literature. Seminars in thrombosis and hemostasis". 41 (3): 323–29. {{cite journal}}: Cite journal requires |journal= (help)
  4. ^
    S2CID 20424049
    .

External links